Patient self-reports in pharmacoeconomic studies. Their use and impact on study validity.
about
Household disposal of pharmaceuticals as a pathway for aquatic contamination in the United kingdom.Official statistics and claims data records indicate non-response and recall bias within survey-based estimates of health care utilization in the older populationComparison of alternative sources of data on health service encounters.Factors affecting the validity of self-reported data on health services from the community health survey in KoreaHealth costs in anthroposophic therapy users: a two-year prospective cohort study.Effect of environment and research participant characteristics on data quality.The association of smoking status with healthcare utilisation, productivity loss and resulting costs: results from the population-based KORA F4 study.Development and first assessment of a questionnaire for health care utilization and costs for cardiac patientsHealth costs in patients treated for depression, in patients with depressive symptoms treated for another chronic disorder, and in non-depressed patients: a two-year prospective cohort study in anthroposophic outpatient settings.Health service utilization in IBD: comparison of self-report and administrative dataValidity of self-reported healthcare utilization data in the Community Health Survey in Korea.Exposure to second-hand smoke and direct healthcare costs in children - results from two German birth cohorts, GINIplus and LISAplus.A comparative analysis of monthly out-of-pocket costs for patients with breast cancer as compared with other common cancers in Ontario, Canada.Change in the prevalence of obesity and use of health care in Denmark: an observational study.Anthroposophic therapy for asthma: A two-year prospective cohort study in routine outpatient settings.A case-control study of the effectiveness of tissue plasminogen activator on 6 month patients--reported outcomes and health care utilization.Productivity losses in chronic obstructive pulmonary disease: a population-based survey.Self-restriction of medications due to cost in seniors without prescription coverageClinical course, costs and predictive factors for response to treatment in carpal tunnel syndrome: the PALMS study protocol.The impact of asthma, chronic bronchitis and allergic rhinitis on all-cause hospitalizations and limitations in daily activities: a population-based observational study.Predictors of frequent recourse to health professionals by people with severe mental disorders.Measuring resource utilization in patient-oriented comparative effectiveness research: a psychometric study of the Resource Utilization Questionnaire.Present and future costs of COPD in Iceland and Norway: results from the BOLD studyRace, ethnicity and differences in contraception among low-income women: methods received by Family PACT Clients, California, 2001-2007.Incidence of utilization- and symptom-defined COPD exacerbations in hospital- and population-recruited patientsOutcome of anthroposophic medication therapy in chronic disease: a 12-month prospective cohort study.Cost burden of type 2 diabetes in Germany: results from the population-based KORA studies.Measurement strategies for indirect costs in economic evaluations.Patient-reported quality of supportive care among patients with colorectal cancer in the Veterans Affairs Health Care System.Empirically derived weights for GMS capitation payments to General Practitioners.The Economic Burden of Obesity in Germany: Results from the Population-Based KORA Studies.Use of school-based health centres for mental health support in Cape Breton, Nova Scotia.Prevalence of disturbed bowel functions and its association with disturbed bladder and sexual functions in the male population.Identifying factors of activities of daily living important for cost and caregiver outcomes in Alzheimer's disease.The personal financial burden of chronic rhinosinusitis: A Canadian perspectivePrescription drug co-payments and cost-related medication underuse.Long-term efficacy of biofeedback therapy in patients with dyssynergic defecation: results of a median 44 months follow-up.Modelling the prevalence and cost of back pain with neuropathic components in the general population.The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort.Unemployment in chronic airflow obstruction around the world: results from the BOLD study.
P2860
Q24811702-E4C994D1-5CE6-4DD3-8182-986AC8EFBDF7Q30584420-FE8D38CC-DECF-4288-B459-97A0D9C4B3D8Q30586239-D6721F0E-611F-4B8E-A78F-3F6569D9372FQ30633118-228098D1-903F-4997-8AD4-41F15F8FAFE9Q30817077-17A15CF1-BEFC-4939-8813-4A7C28FAF6EDQ30975948-7CF273F6-E8B7-4FB9-B0D9-601010BCDCDCQ31123379-DCE0D401-EDCA-4184-B1A6-E09D81FC0117Q33370675-3C1758FB-D419-4837-8CBF-AA84E7D7D22FQ33629358-D1060B50-96A3-42F1-AC10-7F474461AD0FQ33917495-B49B24D9-488E-4DC4-A763-0B150048E7AAQ34069562-11C60A34-E909-4C12-A49A-19DD725AB2C2Q34432166-F1BCE2BA-326D-4C68-9351-56EDA7AC7370Q34541453-EEDB5C48-8F63-4FCF-9CF3-CF9C2C1002ADQ34560366-EB6B809D-7320-4222-9882-8EC04150D9ACQ34623828-EDDFE874-B91D-44AD-BA38-1B736AEB5181Q34633083-88DC36AA-B79A-4B02-8540-3BDB4F68D00CQ34635458-70DE0C36-14DA-46D8-9F10-196D923951CEQ34744672-2E93C92D-2035-4406-8FD1-B1DB294C130AQ35089236-235E0F77-F231-4168-A5D6-D3D5EDFF9172Q35128108-0852E845-F49D-42B9-BCB9-37CD2BB935EBQ35132686-AE688C75-17CE-4890-AD47-CB73AAB055B3Q35612335-4E3CBEE6-B2CE-4163-ACCF-A237B7D03927Q35906562-AFC55502-D043-486F-8557-B59FD2C3304BQ36142643-DB800E79-AF27-425E-AF82-17BAFF8F8453Q37242230-97004F1A-4AE8-4E57-A926-847D8C54C6DAQ37385596-E2EA9004-EB5B-4A31-AF6A-9982ED032C88Q37454933-6A565CF6-1C91-428B-94D2-B81CB291973FQ37609210-8813E88C-B0F5-47B3-9632-522E363CA1C3Q37613960-AE1D03D9-18D3-48B1-8B7A-FF23995F1B86Q39013250-397541B8-D220-4BE6-AF73-59DFA7036898Q39108379-9F14CD65-2331-4D5C-9B7A-69F465593352Q39872051-B87AB0FD-0C38-41ED-B278-CFD6F058D57DQ40053088-F1CE1D8C-D664-4C56-891E-AC86D93F9026Q40607418-81F2E397-5395-41DF-8CFB-DB9AE068A89AQ40958303-33E9F08C-5BC8-48D6-86A4-4919D5C15277Q42662449-411239A9-A016-4738-A8BB-1C36B4ED8CA9Q43331097-A76C9E2D-576E-4002-932E-5B5B9E044198Q46327111-C5B4DE65-4B10-41C3-B99F-7075F9D2F3CFQ47128813-A6022C74-CD71-4C2D-A578-0FCA3E8E2114Q47633012-8021214C-A216-4C58-BD38-A2180295349D
P2860
Patient self-reports in pharmacoeconomic studies. Their use and impact on study validity.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Patient self-reports in pharmacoeconomic studies. Their use and impact on study validity.
@ast
Patient self-reports in pharmacoeconomic studies. Their use and impact on study validity.
@en
type
label
Patient self-reports in pharmacoeconomic studies. Their use and impact on study validity.
@ast
Patient self-reports in pharmacoeconomic studies. Their use and impact on study validity.
@en
prefLabel
Patient self-reports in pharmacoeconomic studies. Their use and impact on study validity.
@ast
Patient self-reports in pharmacoeconomic studies. Their use and impact on study validity.
@en
P1433
P1476
Patient self-reports in pharmacoeconomic studies. Their use and impact on study validity.
@en
P2093
P304
P356
10.2165/00019053-199915030-00004
P577
1999-03-01T00:00:00Z
P6179
1046739489